Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and currently trading at $778.00. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,
15 Billion Reasons to Love Eli Lilly Stock Right Now
Pharmaceutical giant Eli Lilly (NYSE: LLY) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two punch of blockbuster diabetes and obesity care medications, Mounjaro and Zepbound.
18h
What Eli Lilly (NYSE: LLY) is doing is far more impressive. While many investors may buy it for its growth potential, here's ...
(This Dec. 17 story has been corrected to say that the EU regulator reversed its July decision in November to recommend ...
Merck announces a $2.0 billion agreement with Hansoh Pharma. The deal gives it rights to Hansoh's experimental weight-loss ...
Eli Lilly (LLY -1.28%) and Novo Nordisk (NVO 1.03%) have competed for decades. They're both leaders in the areas of insulin ...
5d
Eli Lilly, the pharma giant behind the popular weight-loss drug Zepbound, said it plans to test obesity medications as a ...
The Village of Pleasant Prairie Plan Commission on Monday approved the preliminary site and operational plans for the ...
The summary highlights significant activities in the health sector, including Eli Lilly's Alzheimer's treatment approval in ...
EU regulator reversed its July decision in November to recommend approval for Biogen's drug, Leqembi, in paragraph 8)(Reuters ...
The state will eventually recoup much of that investment when LEAP land is sold to tenants, officials from the Indiana ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback